Substantial somatic genomic variation and selection for BCOR mutations in human induced pluripotent stem cells

Nat Genet. 2022 Sep;54(9):1406-1416. doi: 10.1038/s41588-022-01147-3. Epub 2022 Aug 11.

Abstract

We explored human induced pluripotent stem cells (hiPSCs) derived from different tissues to gain insights into genomic integrity at single-nucleotide resolution. We used genome sequencing data from two large hiPSC repositories involving 696 hiPSCs and daughter subclones. We find ultraviolet light (UV)-related damage in ~72% of skin fibroblast-derived hiPSCs (F-hiPSCs), occasionally resulting in substantial mutagenesis (up to 15 mutations per megabase). We demonstrate remarkable genomic heterogeneity between independent F-hiPSC clones derived during the same round of reprogramming due to oligoclonal fibroblast populations. In contrast, blood-derived hiPSCs (B-hiPSCs) had fewer mutations and no UV damage but a high prevalence of acquired BCOR mutations (26.9% of lines). We reveal strong selection pressure for BCOR mutations in F-hiPSCs and B-hiPSCs and provide evidence that they arise in vitro. Directed differentiation of hiPSCs and RNA sequencing showed that BCOR mutations have functional consequences. Our work strongly suggests that detailed nucleotide-resolution characterization is essential before using hiPSCs.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Cell Differentiation / genetics
  • Genomics
  • Humans
  • Induced Pluripotent Stem Cells*
  • Mutation
  • Nucleotides
  • Proto-Oncogene Proteins / genetics
  • Repressor Proteins / genetics

Substances

  • BCOR protein, human
  • Nucleotides
  • Proto-Oncogene Proteins
  • Repressor Proteins